2018-11-15T16:48:53-06:00 2017-12-31 371611326 ARONSON LLC 805 KING FARM BLVD 3RD FLOOR ROCKVILLE MD 20850 990 2017-01-01 521290067 KERALINK INTERNATIONAL INC KERA 4107523800 5520 RESEARCH PARK DR NO 400 BALTIMORE MD 21228 JOHN MILLER CHIEF FINANCIAL OFFICER 4107523800 2018-11-15 1 GREGORY M PLOTTS CPA P01255941 3012316200 65.242.31.146 2018-11-15 14:12:26 ES P 8121CA463AABFA4EFE5158FD2073B628CA1C8F6D 4911FFCFD6849F9ACA55548C106AAB3A9C09FC8D 2017 2019-02-21 02:37:17Z JOHN MILLER 5520 RESEARCH PARK DR NO 400 BALTIMORE MD 21228 26022471 0 X WWW.TBIONLINE.ORG X 1983 MD FACILITATING DONATION, RETRIEVAL, TESTING AND PROCESSING OF HUMAN TISSUE FOR IMPLANTATION. 10 10 163 0 0 0 44626 292918 8268683 15700639 -1316100 -176702 106 433700 6997315 16250555 0 50000 0 0 3519358 7101878 0 0 401052 5978927 11662693 9498285 18814571 -2500970 -2564016 27053473 23928215 10482041 9284881 16571432 14643334 X TO RELIEVE HUMAN SUFFERING BY FACILITATING THE DONATION, RETRIEVAL, PROCESSING AND EQUITABLE DISTRIBUTION OF OCULAR TISSUE FOR TRANSPLANTATION, RESEARCH, EDUCATION AND OTHER MEDICAL NEEDS WORLDWIDE. 0 0 15345885 50000 15700639 MEDICAL SERVICES OF EYE AND TISSUE BANKING INCLUDING THE RECOVERY, PROCESSING, ANALYSIS, TESTING, AND DISTRIBUTION OF DONATED OCULAR TISSUES. 607609 INTERNATIONAL OPERATIONS 540917 RESEARCH - PROVIDING TISSUES FOR MEDICAL RESEARCH. 316325 PUBLIC HEALTH EDUCATION - EYE & TISSUE DONOR OUTREACH AND DONOR ADVOCACY. 316325 16810736 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 80 0 163 1 0 0 0 0 0 0 0 0 0 0 X 10 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT FL IL KS ME MD MA MI MN MS MO NH NM NY ND OH OK OR PA RI SC TN UT VA WA WV WI NC GA HI NJ X JOHN MILLER 4107523800 5520 RESEARCH PARK DR 400 BALTIMORE MD 21201 JOHN GRANDE DIRECTOR 1.00 X 0 0 0 WILLIAM LYONS DIRECTOR 1.00 X 0 0 0 RANDALL MILLS DIRECTOR 1.00 X 0 0 0 KAREN ORT DIRECTOR 1.00 X 0 0 0 TESSIE SMITH DIRECTOR 1.00 X 0 0 0 WALTER J STARK MD DIRECTOR 1.00 X 0 0 0 THOMAS VANGSNESS MD DIRECTOR 1.00 X 0 0 0 BRYAN VOSSEKUIL DIRECTOR 1.00 X 0 0 0 SAMUEL YIU DIRECTOR 1.00 X 0 0 0 PAMELA HALL DIRECTOR 1.00 X 0 0 0 HARRY CARMITCHEL CHAIRMAN 1.00 X 0 0 0 DOUGLAS J FURLONG VICE CHAIRMAN, CEO/PRESIDENT 40.00 X 396763 0 30875 EDWIN BRUCE CORDELL JR FORMER CFO, TREASURER/SECRETARY 40.00 X 304848 0 14784 ARTHUR KURZ VP, BUSINESS DEVELOPMENT 40.00 X 250072 0 26435 THOMAS M BUCKLEY VP, OPERATIONS 40.00 X 176641 0 7288 MAHMOOD FARAZDAGHI SENIOR VP, INTERNATIONAL 40.00 X 191950 0 8548 CONNIE JONES VP, QRC 40.00 X 200801 0 14735 KATHLEEN TERLIZZESE VP, DEVELOPMENT 40.00 X 144869 0 7338 1665944 0 110003 8 0 1 0 DPR CONSTRUCTION 1450 VETERANS BLVD REDWOOD CITY CA 94063 CONSTRUCTION 1046445 THE LIVING LEGACY FOUNDATION 1730 TWIN SPRINGS ROAD SUITE 200 BALTIMORE MD 21227 TISSUE PROCUREMENT 477500 NEW ENGLAND DONOR SERVICES 60 FIRST AVENUE WALTHAM MA 02451 TISSUE PROCUREMENT 477000 MORIA 1050 CROSS KEYS DRIVE DOYLESTOWN PA 18902 MEDICAL SUPPLIES 455728 4 292918 292918 REIMB TISSUE HANDLING 900099 14347501 14347501 MANAGEMENT FEES 561000 1353138 1353138 15700639 249389 249389 9345825 9771916 -426091 -426091 -426091 RENT REVENUE 900099 378700 378700 ANNUAL ASSESSMENTS 900099 55000 55000 433700 16250555 15700639 0 256998 X 50000 50000 1023777 767833 235469 20475 5794835 5005064 578979 210792 -1000853 46440 -898666 -148627 842103 -27920 760018 110005 442016 387676 40328 14012 165068 124111 37680 3277 87978 67977 18811 1190 32506 24379 7476 651 7091267 6743775 307816 39676 374329 337513 21103 15713 633852 501046 120875 11931 665578 612353 46029 7196 689976 565389 92180 32407 329348 273698 13195 42455 2860 2161 641 58 941548 824610 100992 15946 421460 316095 96936 8429 DUES & SUBSCRIPTIONS 163950 127200 21543 15207 BANK FEES 130426 97934 29916 2576 LAUNDRY 31631 31631 0 0 NEW EMPLOYEE EXPENSES 22837 21637 1056 144 -121921 -89866 -29594 -2461 18814571 16810736 1602783 401052 4549360 0 2681690 2939073 385274 754770 536778 482005 8089624 2504301 13078344 5585323 5329443 13250708 10329 426184 549674 66400 356333 27053473 23928215 9605394 8432301 876647 852580 10482041 9284881 X 16571432 14633334 10000 16571432 14643334 27053473 23928215 -2564016 860788 -224870 0 X 0 1 X 0 0 X 107768 141076 40134 44626 292918 626522 59709793 47077532 27068296 8268683 15700639 157824943 59817561 47218608 27108430 8313309 15993557 158451465 0 33747697 27502410 2287893 2125382 65663382 33747697 27502410 2287893 2125382 65663382 92788083 8144 510 20752 452 249389 279247 8144 510 20752 452 249389 279247 42442 5371 45955 106 433700 527574 59868147 47224489 27175137 8313867 16676646 159258286 0.58260 0.55210 0.00180 0.00060 X 4792206 579124 4213082 3297418 1925177 1372241 5585323 DUE TO AFFILIATE 140745 DEFERRED RENT 687158 BANK OVERDRAWN 24677 852580 X 17111343 860788 860788 16250555 0 16250555 18814571 0 18814571 0 18814571 PART X, LINE 2: FINANCIAL STATEMENT FOOTNOTE REGARDING FIN 48 (ASC 740) KLI EVALUATES UNCERTAINTY IN INCOME TAX POSITIONS BASED ON A MORE-LIKELY-THAN-NOT RECOGNITION STANDARD. IF THAT THRESHOLD IS MET, THE TAX POSITION IS THEN MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED UPON ULTIMATE SETTLEMENT. AS OF DECEMBER 31, 2017, THERE ARE NO ACCRUALS FOR UNCERTAIN TAX POSITIONS. IF APPLICABLE, KLI RECORDS INTEREST AND PENALTIES AS A COMPONENT OF INCOME TAX EXPENSE. TAX YEARS FROM 2015 THROUGH THE CURRENT YEAR REMAIN OPEN FOR EXAMINATION BY FEDERAL AND STATE TAX AUTHORITIES. 1 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EYE TISSUE BANKING 127100 EUROPE 0 0 PROGRAM SERVICES EYE TISSUE BANKING 354470 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES EYE TISSUE BANKING 496150 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES EYE TISSUE BANKING 16190 0 0 0 0 0 0 993910 0 993910 0 0 0 0 0 0 PART I, LINE 3: INTERNATIONAL PROGRAM EXPENSES THE ACCOUNTING SYSTEM USED DOES NOT TRACK EXPENDITURES BY REGION THEREFORE THE AMOUNTS LISTED IN PART I LINE 3 ARE ESTIMATES WHICH IN AGGREGATE ARE THE TOTAL OF INTERNATIONAL PROGRAM EXPENSES. 1 THE JOHN HOPKINS HOSPITAL 600 N WOLFE STREET BALTIMORE MD 21287 520591656 501 (C) (3) 50000 GENERAL SUPPORT 1 PART I, LINE 2: PROCEDURES FOR MONITORING GRANTS GRANTS ARE PROVIDED TO DOMESTIC ORGANIZATION FOR GENERAL SUPPORT AND THE USE OF THE FUNDS ARE MONITORED THROUGH FOLLOW-UP COMMUNICATIONS AND PERIODIC REPORTING. X X X X X X 0 0 0 0 0 0 0 0 0 DOUGLAS J FURLONG VICE CHAIRMAN, CEO/PRESIDENT 380000 0 25000 0 -8237 0 13258 0 17617 0 427638 0 0 0 EDWIN BRUCE CORDELL JR FORMER CFO, TREASURER/SECRETARY 211615 0 25000 0 68233 0 8466 0 6318 0 319632 0 0 0 ARTHUR KURZ VP, BUSINESS DEVELOPMENT 231000 0 27683 0 -8611 0 9562 0 16873 0 276507 0 0 0 THOMAS M BUCKLEY VP, OPERATIONS 175000 0 0 0 1641 0 5211 0 2077 0 183929 0 0 0 MAHMOOD FARAZDAGHI SENIOR VP, INTERNATIONAL 167923 0 0 0 24027 0 6717 0 1831 0 200498 0 0 0 CONNIE JONES VP, QRC 200000 0 0 0 801 0 8003 0 6732 0 215536 0 0 0 KATHLEEN TERLIZZESE VP, DEVELOPMENT 143000 0 0 0 1869 0 5625 0 1713 0 152207 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM AND REVIEWED BY THE CHIEF FINANCIAL OFFICER BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C PROCESS FOR MONITORING THE CONFLICT OF INTEREST POLICY ALL NEW EMPLOYEES OF THE ORGANIZATION ARE REQUIRED TO REVIEW AND ACKNOWLEDGE COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. OFFICER'S, DIRECTORS, AND KEY EMPLOYEES OF THE ORGANIZATION ARE REQUIRED ANNUALLY TO REVIEW AND AFFIRM COMPLIANCE WITH THE POLICY. OFFICERS AND DIRECTORS ARE EXPECTED TO REPORT ANY ACTUAL OR POTENTIALLY MATERIAL CONFLICTS TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND ACTION. ADDITIONALLY ACTUAL OR POTENTIAL CONFLICTS IDENTIFIED ON BEHALF OF ANY TISSUE BANKS INTERNATIONAL EMPLOYEE WILL BE COMMUNICATED TO EXECUTIVE MANAGMENT FOR INVESTIGATION AND RESOLUTION. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING TOP MANAGEMENT OFFICIAL COMPENSATION MEMBERS OF THE BOARD OF DIRECTORS (COMPENSATION COMMITTEE) CONDUCT AN EXECUTIVE COMPENSATION REVIEW ANNUALLY TO SET THE CEO'S COMPENSATION. THE COMPENSATION COMMITTEE INCORPORATES COMPENSATION SURVEY DATA, REVIEW OF FORM 990 FROM COMPANIES IN RELATED INDUSTRIES AND OF SIMILAR SIZE MEASUREMENT OF BOARD SET PERFORMANCE OBJECTIVES ARE ALSO USED TO SET CEO'S ANNUAL COMPENSATION. THE ORGANIZATIONS CEO IS RESPONSIBLE FOR SETTING AND REVIEWING THE COMPENSATION OF KERALINK INTERNATIONAL, INC.'S SENIOR MANAGEMENT TEAM. MARKET COMPENSATION DATA, INDEPENDENT COMPENSATION ANALYSIS AND INDIVIDUAL PERFORMANCE AGAINST OPERATIONAL OBJECTIVES ARE ALL FACTORED INTO THE REVIEW. FORM 990, PART VI, SECTION C, LINE 19 CERTAIN DOCUMENTS AVAILABILITY TO THE PUBLIC EACH YEAR THE ORGANIZATION PROVIDES AN "ANNUAL REPORT" ON ACTIVITIES, ACHIEVEMENTS AND SERVICES PROVIDED WHICH ALSO INCLUDES A SUMMARY STATEMENT OF ACTIVITIES/REVENUES AND EXPENSES. THE ORGANIZATION PROVIDES PUBLIC ACCESS TO THE ANNUAL REPORT AS WELL AS OTHER DOCUMENTS ON ITS WEBSITE. DOCUMENTS NOT ON THE WEBSITE ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G PROFESSIONAL SERVICES - MEDICAL: PROGRAM SERVICE EXPENSES 6,273,015. MANAGEMENT AND GENERAL EXPENSES 208,490. FUNDRAISING EXPENSES 1,217. TOTAL EXPENSES 6,482,722. OUTSIDE CONSULTANTS: PROGRAM SERVICE EXPENSES 470,760. MANAGEMENT AND GENERAL EXPENSES 99,326. FUNDRAISING EXPENSES 38,459. TOTAL EXPENSES 608,545.